Literature DB >> 14653950

Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line.

Lei Wang1, Gui-Mei Zhang, Zuo-Hua Feng.   

Abstract

AIM: To investigate the ability of an antisense RNA eukaryotic expression plasmid pcDNA3.1/survivin in down-regulating the expression level of survivin mRNA and survivin protein and reversed multidrug resistance (MDR) in adriamycin-resistant HL-60/ADR cell line.
METHODS: The expression of survivin mRNA was measured by RT-PCR and the expression of survivin protein was measured by Western blot. Caspase-3 activity was determined by Phar Mingen colorimetric assay kit. Apoptosis was assessed by flow cytometry. The chemosensitivity of HL-60/ADR cells to adriamycin (ADR) was measured by MTT assay.
RESULTS: pcDNA3.1/survivin down-regulated the expression level of survivin mRNA and survivin protein obviously, and induced apoptosis of HL-60/ADR cells in a time-dependent manner during 12-48 h. After transient transfection with pcDNA3.1/survivin for 48 h, survivin mRNA decreased by 67 %, survivin protein decreased by 57 %, caspase-3 activity increased 4.37 times, and the apoptosis rate increased by 4.41 % compared with control. Compared with ADR alone, pcDNA3.1/survivin significantly reversed MDR in HL-60/ADR cells, the chemosensitivity of HL-60/ADR cells to ADR was increased to 5.36 folds.
CONCLUSION: pcDNA3.1/survivin down-regulated the expression level of survivin mRNA and survivin protein obviously, the threshold of apoptosis was decreased and MDR was reversed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14653950

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  10 in total

Review 1.  Survivin and leukemia.

Authors:  Xiu Li Cong; Zhong Chao Han
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

Review 2.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

3.  Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.

Authors:  Riccardo Seta; Marco Mascitti; Roberto Campagna; Davide Sartini; Stefania Fumarola; Andrea Santarelli; Michele Giuliani; Monia Cecati; Lorenzo Lo Muzio; Monica Emanuelli
Journal:  Clin Oral Investig       Date:  2018-06-07       Impact factor: 3.573

4.  The role of survivin in diagnosis, prognosis and treatment of breast cancer.

Authors:  Yong-Gang Lv; Fang Yu; Qing Yao; Jiang-Hao Chen; Ling Wang
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

5.  Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.

Authors:  Neeraj Kapur; Hina Mir; Guru P Sonpavde; Sanjay Jain; Sejong Bae; James W Lillard; Shailesh Singh
Journal:  Cancer Lett       Date:  2019-04-08       Impact factor: 8.679

6.  Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin.

Authors:  Xiang Ling; Xiang He; Pasha Apontes; Felicia Cao; Rami G Azrak; Fengzhi Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

7.  Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR.

Authors:  Yu Jia Wang; Huan Dong Zhao; Cai Feng Zhu; Jian Li; Hong Juan Xie; Yu Xiang Chen
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

8.  Metabolic Reprogramming During Multidrug Resistance in Leukemias.

Authors:  Raphael Silveira Vidal; Julia Quarti; Mariana Figueiredo Rodrigues; Franklin D Rumjanek; Vivian M Rumjanek
Journal:  Front Oncol       Date:  2018-04-04       Impact factor: 6.244

9.  Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells.

Authors:  Baoan Chen; Yiqiong Liang; Weiwei Wu; Jian Cheng; Guohua Xia; Feng Gao; Jiahua Ding; Chong Gao; Zeye Shao; Guohong Li; Wenji Chen; Wenlin Xu; Xinchen Sun; Lijie Liu; Xiaomao Li; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2009

10.  Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.

Authors:  Hiroki Yamazaki; Satoshi Takagi; Yuki Hoshino; Kenji Hosoya; Masahiro Okumura
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.